BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17718519)

  • 1. Structural and biochemical studies of botulinum neurotoxin serotype C1 light chain protease: implications for dual substrate specificity.
    Jin R; Sikorra S; Stegmann CM; Pich A; Binz T; Brunger AT
    Biochemistry; 2007 Sep; 46(37):10685-93. PubMed ID: 17718519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate recognition mechanism of VAMP/synaptobrevin-cleaving clostridial neurotoxins.
    Sikorra S; Henke T; Galli T; Binz T
    J Biol Chem; 2008 Jul; 283(30):21145-52. PubMed ID: 18511418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
    Agarwal R; Binz T; Swaminathan S
    Biochemistry; 2005 Sep; 44(35):11758-65. PubMed ID: 16128577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple pocket recognition of SNAP25 by botulinum neurotoxin serotype E.
    Chen S; Barbieri JT
    J Biol Chem; 2007 Aug; 282(35):25540-7. PubMed ID: 17609207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of SNAP-25 isoforms by botulinum neurotoxin types A, C, and E: domains and amino acid residues controlling the formation of enzyme-substrate complexes and cleavage.
    Vaidyanathan VV; Yoshino K; Jahnz M; Dörries C; Bade S; Nauenburg S; Niemann H; Binz T
    J Neurochem; 1999 Jan; 72(1):327-37. PubMed ID: 9886085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of botulinum neurotoxin type G light chain: serotype divergence in substrate recognition.
    Arndt JW; Yu W; Bi F; Stevens RC
    Biochemistry; 2005 Jul; 44(28):9574-80. PubMed ID: 16008342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
    Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
    Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxin B recognizes its protein receptor with high affinity and specificity.
    Jin R; Rummel A; Binz T; Brunger AT
    Nature; 2006 Dec; 444(7122):1092-5. PubMed ID: 17167421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
    Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
    J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of substrate recognition and specificity of botulinum neurotoxin serotype F.
    Chen S; Wan HY
    Biochem J; 2011 Jan; 433(2):277-84. PubMed ID: 21029044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity.
    Rawat R; Ashraf Ahmed S; Swaminathan S
    Protein Expr Purif; 2008 Aug; 60(2):165-9. PubMed ID: 18482846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique substrate recognition by botulinum neurotoxins serotypes A and E.
    Chen S; Barbieri JT
    J Biol Chem; 2006 Apr; 281(16):10906-11. PubMed ID: 16478727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
    Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
    FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
    Agarwal R; Swaminathan S
    J Biol Chem; 2008 Sep; 283(38):25944-51. PubMed ID: 18658150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocrystal structure of synaptobrevin-II bound to botulinum neurotoxin type B at 2.0 A resolution.
    Hanson MA; Stevens RC
    Nat Struct Biol; 2000 Aug; 7(8):687-92. PubMed ID: 10932255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
    Zanetti G; Sikorra S; Rummel A; Krez N; Duregotti E; Negro S; Henke T; Rossetto O; Binz T; Pirazzini M
    PLoS Pathog; 2017 Aug; 13(8):e1006567. PubMed ID: 28800600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
    Carle S; Pirazzini M; Rossetto O; Barth H; Montecucco C
    Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29257047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins.
    Pellizzari R; Rossetto O; Lozzi L; Giovedi' S; Johnson E; Shone CC; Montecucco C
    J Biol Chem; 1996 Aug; 271(34):20353-8. PubMed ID: 8702770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate recognition strategy for botulinum neurotoxin serotype A.
    Breidenbach MA; Brunger AT
    Nature; 2004 Dec; 432(7019):925-9. PubMed ID: 15592454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.